• Jane Bak
  • Kamilla Bak Dyrby
4. term, Clinical Science and Technology, Master (Master Programme)
Diabetes Mellitus type 1 is a complex disease in which blood glucose, insulin, carbohydrate and activity are inseparable in the daily treatment. To achieve the treatment goal the patient must have good self-management. It is crucial that children and adolescents receive the right support to deal with the complexity of their treatment. There are many technologies in the diabetes treatment, but a lot of them only handle some off the treatment, they are not compatible with each other and often decision support only is integrated do to insulin dosing.
Based on the literature, low fidelity prototype and Muller et als heuristics the high fidelity protype ‘Mit Blodsukker’ is designed. The high fidelity prototype has been evaluated by four evaluators through Participatory Heuristic Evaluation.
A design for children and adolescents with type 1 diabetes should be highly individualized and directly support the diabetic to achieve increased self-management. The design should support the technologies used in the treatment and guide the user through decision support for managing their disease.
The PHE of the high fidelity prototype resulted in 87 violations of the heuristics and had and average severity of 2.7 on a scale of 1-4.
Based on the thesis focusing on the area, it can be assumed that the design solution behind ‘Mit Blodsukker’ can support children and adolescents in self-management of diabetes and improve the treatment goals through individualized decision support, visualization of own data, as they achieve learning about their illness.
Publication date19 Jun 2019
Number of pages60
ID: 305188214